Regenetech was incorporated in 2002. Since then, Regenetech has licensed 13 patents from NASA, and so has the additional benefit of over 20 years (and over $100,000,000) of NASA research supporting its work.

Regenetech’s initial proof of concept work was done at M.D. Anderson Cancer Center in Houston. From there, NASA agreed to assist in the research, and for the next three years, Regenetech’s research was conducted at NASA under a Reimbursable Space Act Agreement. When NASA began closing its Life Sciences research, Regenetech opened its own lab in Houston. Accordingly, many of Regenetech’s most advanced discoveries have been made in Regenetech’s own lab.

With its patent portfolio, Regenetech has been able to develop an aggressive licensing policy, licensing its technology and patent portfolio throughout the world.